287 related articles for article (PubMed ID: 9740247)
1. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions.
Geertsen RC; Hofbauer GF; Yue FY; Manolio S; Burg G; Dummer R
J Invest Dermatol; 1998 Sep; 111(3):497-502. PubMed ID: 9740247
[TBL] [Abstract][Full Text] [Related]
2. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
[TBL] [Abstract][Full Text] [Related]
4. Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
Willers J; Urosevic M; Laine E; Geertsen R; Kündig T; Burg G; Dummer R
J Invest Dermatol; 2001 Dec; 117(6):1498-504. PubMed ID: 11886514
[TBL] [Abstract][Full Text] [Related]
5. Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.
Akiyama Y; Maruyama K; Tai S; Takikawa M; Ohshita C; Yamamoto A; Yamazaki N; Kiyohara Y; Yamaguchi K
Int J Oncol; 2008 Sep; 33(3):433-41. PubMed ID: 18695871
[TBL] [Abstract][Full Text] [Related]
6. Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN-gamma in melanoma cell cultures established from CNS lesions.
Geertsen R; Zenklusen R; Kamarashev J; Burg G; Dummer R
Int J Cancer; 1999 Sep; 83(1):135-40. PubMed ID: 10449620
[TBL] [Abstract][Full Text] [Related]
7. Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.
Xu Y; Theobald V; Sung C; DePalma K; Atwater L; Seiger K; Perricone MA; Richards SM
J Transl Med; 2008 Oct; 6():61. PubMed ID: 18945350
[TBL] [Abstract][Full Text] [Related]
8. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.
Kageshita T; Wang Z; Calorini L; Yoshii A; Kimura T; Ono T; Gattoni-Celli S; Ferrone S
Cancer Res; 1993 Jul; 53(14):3349-54. PubMed ID: 7686817
[TBL] [Abstract][Full Text] [Related]
9. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
10. Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.
Griffioen M; Borghi M; Schrier PI; Osanto S; Schadendorf D
Cancer Immunol Immunother; 2004 Aug; 53(8):715-22. PubMed ID: 14997347
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the immunological effects of 5-azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
Frøsig TM
Dan Med J; 2015 Aug; 62(8):B5144. PubMed ID: 26239596
[TBL] [Abstract][Full Text] [Related]
12. Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations.
Geertsen R; Böni R; Blasczyk R; Romero P; Betts D; Rimoldi D; Hong X; Laine E; Willers J; Dummer R
Int J Cancer; 2002 May; 99(1):82-7. PubMed ID: 11948496
[TBL] [Abstract][Full Text] [Related]
13. Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.
Dhodapkar MV; Young JW; Chapman PB; Cox WI; Fonteneau JF; Amigorena S; Houghton AN; Steinman RM; Bhardwaj N
Clin Cancer Res; 2000 Dec; 6(12):4831-8. PubMed ID: 11156242
[TBL] [Abstract][Full Text] [Related]
14. Induction of tyrosinase-reactive T cells by treatment with dacarbazine, cisplatin, interferon-alpha +/- interleukin-2 in patients with metastatic melanoma.
Schmittel A; Keilholz U; Max R; Thiel E; Scheibenbogen C
Int J Cancer; 1999 Jan; 80(1):39-43. PubMed ID: 9935227
[TBL] [Abstract][Full Text] [Related]
15. Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
Fonsatti E; Nicolay HJ; Sigalotti L; Calabrò L; Pezzani L; Colizzi F; Altomonte M; Guidoboni M; Marincola FM; Maio M
Clin Cancer Res; 2007 Jun; 13(11):3333-8. PubMed ID: 17545540
[TBL] [Abstract][Full Text] [Related]
16. Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures.
Hofbauer GF; Geertsen R; Laine E; Burg G; Dummer R
Melanoma Res; 2001 Jun; 11(3):213-8. PubMed ID: 11468509
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules.
Yue FY; Dummer R; Geertsen R; Hofbauer G; Laine E; Manolio S; Burg G
Int J Cancer; 1997 May; 71(4):630-7. PubMed ID: 9178819
[TBL] [Abstract][Full Text] [Related]
18. Umbilical cord blood T cells respond against the Melan-A/MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells.
Merindol N; Grenier AJ; Caty M; Charrier E; Duval A; Duval M; Champagne MA; Soudeyns H
J Immunol; 2010 Jul; 185(2):856-66. PubMed ID: 20543110
[TBL] [Abstract][Full Text] [Related]
19. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
Mortarini R; Borri A; Tragni G; Bersani I; Vegetti C; Bajetta E; Pilotti S; Cerundolo V; Anichini A
Cancer Res; 2000 Jul; 60(13):3559-68. PubMed ID: 10910069
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of human and mouse beta 2-microglobulin on the induction and the antigenic profile of endogenous HLA-A and -B antigens synthesized by beta 2-microglobulin gene-null FO-1 melanoma cells.
Wang Z; Hu XZ; Tatake RJ; Yang SY; Zeff RA; Ferrone S
Cancer Res; 1993 Sep; 53(18):4303-9. PubMed ID: 7689931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]